Novel technology discriminates normal and ectatic eyes

Did you miss the July 11th issue of the Ophthalmology Times eReport? In this e-newsletter we released information on discriminating the difference between normal and biomechanically compromised or ectatic corneas, a new CPT code for the procedure used to implant miniature ophthalmic telescopes, new chair appointments at New York University and more. Check out the articles in this issue below.

Novel technology discriminates normal and ectatic eyes

Measurement of corneal parameters using dynamic ultra-high-speed Scheimpflug photography (CorVis ST, Oculus) is an effective method for discriminating between normal and biomechanically compromised or ectatic corneas, including very mild cases of forme fruste keratoconus (FFKC), according to the results of a retrospective study reported by Renato Ambrosio Jr., MD, PhD. Read more

Dispersive OVD gains FDA approval

The FDA has approved a dispersive ophthalmic viscosurgical device (OVD) (Healon EndoCoat OVD, Abbott Medical Optics) for use as a surgical aid in cataract extraction and IOL implantation. Read more

New CPT code for telescope implant

The American Medical Association (AMA) has released a new Current Procedural Terminology (CPT) code for the procedure used to implant miniature ophthalmic telescopes (Implantable Miniature Telescope [by Dr. Isaac Lipshitz], VisionCare Ophthalmic Technologies). Read more

Ocriplasmin BLA granted priority review

ThromboGenics NV has announced that the FDA has accepted the filing of the biologics license application (BLA) for ocriplasmin intravitreal injection 2.5 mg/ml and granted it priority review. The proposed indication of ocriplasmin intravitreal injection is for the treatment of symptomatic vitreomacular adhesion (VMA) including macular hole. Read more

Survey finds increased satisfaction with eye care

Satisfaction is increasing among patients who have a regular eye-care professional, according to a new survey. Read more

Drs. Galetta, Balcer to join NYU Langone

Steven L. Galetta, MD, has been appointed the Philip K. Moskowitz, MD, Professor and Chair of the department of neurology, and Laura Balcer, MD, MSCE, has been appointed vice chairwoman of the neurology department at the New York University (NYU) Langone Medical Center. The appointments are effective Nov. 1. Read more

Top 5 Updates on Cataracts in 2012

From femtosecond platforms to how cataracts effects driving, eye-care news in regards to cataracts has been quite eventful this year. The following links are to our hand-picked cataracts news pieces from Ophthalmology Times that we think you’ll be interested in.

Cataracts, blurred vision ‘severely’ effected driving

Results of motor vehicles agency-administered vision tests do not necessarily reflect fitness to drive, according to a study published in Investigative Ophthalmology & Visual Science. Read more

New CE mark adds utility for laser platform

OptiMedica Corp. has announced that its proprietary platform that combines a femtosecond laser, integrated three-dimensional optical coherence tomography (OCT) imaging, and a proprietary pattern-scanning technology (Catalys Precision Laser System) has been granted CE mark approval for creating single-plane and multi-plane arc cuts/incisions in the cornea during cataract surgery. Read more

Biometry, IOL power formulae improve outcomes

Accuracy of IOL power calculation can be significantly increased through the use of a low-coherence laser interferometry device (Lenstar LS900, Haag-Streit) for optical biometry combined with a last-generation, four-variable, “paraxial” ray-tracing formula (Olsen formula; PhacoOptics software, IOL Innovations). The benefit is due to improved prediction of postoperative IOL position, said Thomas Olsen, MD. Read more

Surgeon Dr. Robert Welsh dies

Robert C. Welsh, MD, believed to be the first U.S. surgeon to limit his practice to cataract surgery, died Jan. 8. He was 89. Read more

FDA clears femtosecond laser program

The FDA has cleared a new femtosecond laser platform (Femto LDV Z Models, Ziemer Ophthalmic Systems AG). The platform has been released globally. Read more